The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Focused Issues

당뇨병 치료에서 주사제의 선택: 인슐린 대 인크레틴: 안강희; J Korean Diabetes. 2025;26(1):28-31. Published online March 30, 2025; DOI: https://doi.org/10.4093/jkd.2025.26.1.28

Statement

당뇨병신장질환에서 GLP-1수용체작용제의 역할: 최근 연구 결과: 김진화; J Korean Diabetes. 2025;26(1):5-9. Published online March 30, 2025; DOI: https://doi.org/10.4093/jkd.2025.26.1.5

Focused Issues

비만당뇨병의 관리 전략: 김미숙, 이승환; J Korean Diabetes. 2024;25(3):165-171. Published online September 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.3.165

글루카곤 수용체작용제의 기전 및 GLP-1/글루카곤/GIP수용체 삼중 효현제의 효과: 민세희; J Korean Diabetes. 2024;25(2):82-88. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.82

GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로: 오태정; J Korean Diabetes. 2024;25(2):76-81. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.76
Cited By 1

GLP-1수용체작용제: 정승민; J Korean Diabetes. 2024;25(2):69-75. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.69

Opinion

Glucagon-Like Peptide-1수용체작용제의 전 세계적 품절 사태: 이동원; J Korean Diabetes. 2024;25(1):1-3. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.1

Information Desks

최신 당뇨병 치료제의 특징: 윤누리; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Focused Issues

Glucagon-Like Peptide 1 수용체작용제 최신지견: 김혜진; J Korean Diabetes. 2021;22(2):126-133. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.126
Cited By 6

당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제: Inkuk Lee, Eun Seok Kang; J Korean Diabetes. 2019;20(3):149-156. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.149
Cited By 1

Opinion

삭센다? 열풍, 내분비대사내과 전문의로서의 의견: Sungrae Kim; J Korean Diabetes. 2019;20(2):63-66. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.63

식사 중 탄수화물은 언제 먹어야 하나: Jae Hyun Bae, Young Min Cho; J Korean Diabetes. 2018;19(4):193-199. Published online January 8, 2019; DOI: https://doi.org/10.4093/jkd.2018.19.4.193
Cited By 1

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71
Cited By 1

Focused Issues

제2형 당뇨병 약제치료 지침 2017 개정안: Glucagon-Like Peptide-1 수용체작용제: Hyun Jin Kim; J Korean Diabetes. 2018;19(1):35-40. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.35
Cited By 1

글루카곤양 펩티드-1 수용체 작용제의 임상적 적용: Se Hee Min, Young Min Cho; J Korean Diabetes. 2015;16(4):252-259. Published online December 24, 2015; DOI: https://doi.org/10.4093/jkd.2015.16.4.252

Volume 26, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

4,074	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
6,118	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
2,957	SGLT2 Inhibitors and Diabetes: Where Does It Come from and Where Does It Go?
2,087	Community-Based Intervention for Elderly Patients with Diabetes Mellitus: Assessing the Effectiveness of a YouTube Self-Education Program during the Global COVID-19 Pandemic
2,205	A Young Adult’s Life with Diabetes Based on a Social Ecological Model

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2025 by Korean Diabetes Association. All rights reserved.